IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.
Free access to all Sound Bites content
Published 1 week
Medical Professional
ctDNA and RCB
Dr. Joe Mendez reviews the watch and wait vorasidenib patient profile in low-grade gliomas (Video 3/3)
Joe Mendez, MD
Dr. Ghaith Abu-Zeinah reviews the risks and threats in essential thrombocythemia (Video 2/3)
Ghaith Abu-Zeinah, MD
Dr. Laura van ‘t Veer describes the residual cancer burden with ctDNA in breast cancer (Video 3/3)
Laura van 't Veer, PhD
Dr. Sandip Patel reviews the benefit of adding local consolidative treatment to 1L osimertinib in EGFRm mNSCLC. (Video 2/3)
Sandip Patel, MD
Dr. Ghaith Abu-Zeinah explores why essential thrombocythemia matters and the current unmet needs in patient care (Video 1/3)
Ghaith Abu-Zeinah, MD
Dr. Joshua Richter reviews the safety profile and AE management of MeziKd (Video 2/3)
Joshua Richter, MD